UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

Annals of oncology, 2008-04, Vol.19 (4), p.734-738

2008

Volltextzugriff (PDF)

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study

Annals of oncology, 2017-09, Vol.28 (9), p.2128-2134

2017

Volltextzugriff (PDF)

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

The lancet oncology, 2019-03, Vol.20 (3), p.420-435

2019

Volltextzugriff (PDF)

Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper

Annals of oncology, 2011-02, Vol.22 (2), p.257-267

2011

Volltextzugriff (PDF)

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study

Annals of oncology, 2012-11, Vol.23 (11), p.2896-2902

2012

Volltextzugriff (PDF)

Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients

Investigational new drugs, 2015-12, Vol.33 (6), p.1242-1247

2015

Volltextzugriff (PDF)

The first study published?

Annals of oncology, 2015-08, Vol.26 (8), p.1803-1803

2015

Volltextzugriff (PDF)

Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice

Supportive care in cancer, 2014-03, Vol.22 (3), p.667-677

2014

Volltextzugriff (PDF)

Influence of primary tumour sidedness on survival after upfront primary tumour resection (PTR) in synchronous metastatic colon cancer (mCC)

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii177-viii178

2018

Volltextzugriff (PDF)

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

Breast cancer research and treatment, 2011-07, Vol.128 (2), p.437-445

2011

Volltextzugriff (PDF)

The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry

Acta oncologica, 2020-01, Vol.59 (1), p.82-89

2020

Volltextzugriff (PDF)

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study

Annals of oncology, 2006-10, Vol.17 (10), p.1523-1528

2006

Volltextzugriff (PDF)

Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2

European journal of cancer (1990), 2017-02, Vol.72, p.S1-S2

2017

Volltextzugriff (PDF)

A lung cancer patient with painful fingers

Netherlands journal of medicine, 2014-10, Vol.72 (8), p.431, 435-435

2014

Volltextzugriff (PDF)

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

Annals of oncology, 2004-10, Vol.15 (10), p.1527-1534

2004

Volltextzugriff (PDF)

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

The New England journal of medicine, 2015-07, Vol.373 (3), p.209-219

2015

Volltextzugriff (PDF)

Thorium dioxide-related haemangiosarcoma of the liver

Netherlands journal of medicine, 2007-09, Vol.65 (8), p.279-282

2007

Volltextzugriff (PDF)

Sclerosing peritonitis : an unusual cause of ascites in a patient with systemic lupus erythematosus

Netherlands journal of medicine, 2006-10, Vol.64 (9), p.346-349

2006

Volltextzugriff (PDF)

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

Journal of clinical oncology, 1996-04, Vol.14 (4), p.1077-1084

1996

Volltextzugriff (PDF)

Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reports

International journal of clinical pharmacology and therapeutics, 2011-01, Vol.49 (1), p.46-48

2011

Volltextzugriff (PDF)

352P Cost-effectiveness of CDK4/6 inhibitors in first- vs second-line for advanced breast cancer (ABC) in the phase III SONIA trial (BOOG 2017-03)

Annals of oncology, 2024-09, Vol.35, p.S364-S364

2024

Volltextzugriff (PDF)

Transanal total mesorectal excision and low anterior resection syndrome

British journal of surgery, 2021-08, Vol.108 (8), p.991-997

2021

Volltextzugriff (PDF)

Influence on quality of life of chemotherapy scheduling for patients with advanced HER2-negative breast cancer

Annals of oncology, 2019-05, Vol.30, p.iii51-iii51

2019

Volltextzugriff (PDF)

Intermittent versus continuous chemotherapy beyond first-line for patients with HER2-negative advanced breast cancer (BOOG 2010-02)

Annals of oncology, 2019-05, Vol.30, p.iii50-iii51

2019

Volltextzugriff (PDF)

159P_PRInfluence on quality of life of chemotherapy scheduling for patients with advanced HER2-negative breast cancer

Annals of oncology, 2019-05, Vol.30 (Supplement_3)

2019

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(106)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(61)
Science & Technology
(59)
Life Sciences & Biomedicine
(58)
Female
(37)
Middle Aged
(37)
Oncology
(33)
Biological And Medical Sciences
(29)
Male
(29)
Medical Sciences
(29)
Aged
(28)
Adult
(24)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(19)
Treatment Outcome
(14)
Chemotherapy
(13)
General & Internal Medicine
(13)
Medicine, General & Internal
(13)
Tumors
(13)
Pharmacology. Drug Treatments
(12)
Prognosis
(12)
Aged, 80 And Over
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Anthracycline cardiotoxicity in the elderly cancer patient: a SIOG expert position paper

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study

Safety and efficacy of the addition of simvastatin to cetuximab in previously treated KRAS mutant metastatic colorectal cancer patients

The first study published?

Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy—findings from clinical practice

Influence of primary tumour sidedness on survival after upfront primary tumour resection (PTR) in synchronous metastatic colon cancer (mCC)

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy

The relative effectiveness of eribulin for advanced breast cancer treatment: a study of the southeast Netherlands advanced breast cancer registry

Randomised study of sequential versus combination chemotherapy with capecitabine, irinotecan and oxaliplatin in advanced colorectal cancer, an interim safety analysis. A Dutch Colorectal Cancer Group (DCCG) phase III study

Efficacy and safety of ribociclib (LEE011) + letrozole in elderly patients with hormone receptor-positive (HR+), HER2-negative (HER2−) advanced breast cancer (ABC) in MONALEESA-2

A lung cancer patient with painful fingers

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

Thorium dioxide-related haemangiosarcoma of the liver

Sclerosing peritonitis : an unusual cause of ascites in a patient with systemic lupus erythematosus

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

Toxic dermatitis in patients treated with Taxotere® (docetaxel): three case reports

352P Cost-effectiveness of CDK4/6 inhibitors in first- vs second-line for advanced breast cancer (ABC) in the phase III SONIA trial (BOOG 2017-03)

Transanal total mesorectal excision and low anterior resection syndrome

Influence on quality of life of chemotherapy scheduling for patients with advanced HER2-negative breast cancer

Intermittent versus continuous chemotherapy beyond first-line for patients with HER2-negative advanced breast cancer (BOOG 2010-02)

159P_PRInfluence on quality of life of chemotherapy scheduling for patients with advanced HER2-negative breast cancer

Suchergebnisse filtern